Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Monte Rosa Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19
Revenues0.00.07.4
            Revenue growth -100.0% 
Cost of goods sold0.00.014.7
Gross profit0.00.0-7.4
            Gross margin  -100.0%
Selling, general and administrative72.928.0 
General and administrative  0.6
EBIT-75.0-43.7-8.0
            EBIT margin  -108.8%
Pre-tax income-74.0-35.9-7.7
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income-74.0-35.9-7.7
            Net margin  -105.3%
 
Diluted EPS($2.96)($23.65)($5.47)
Shares outstanding (diluted)25.01.51.4
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy